
Diagnostics, Год журнала: 2024, Номер 14(23), С. 2674 - 2674
Опубликована: Ноя. 27, 2024
Interstitial lung disease (ILD) is one of the common and potentially lethal manifestations systemic autoimmune rheumatic diseases (SARDs). ILD’s prevalence, clinical patterns, imaging, natural history are variable. Each representative diseases—systemic sclerosis (SSc), idiopathic inflammatory myopathies (IIMs), rheumatoid arthritis (RA), Sjӧgren’s syndrome (SjS), mixed connective tissue (MCTD), lupus erythematosus (SLE)—have distinct clinical, paraclinical evolutionary features. Risk factors with predictive value for ILD have been identified. This review summarizes, from clinician’s perspective, recent data literature regarding specificity each diseases, an emphasis on role multidisciplinary team in early diagnosis, case management, as well particularities approach to progressive phenotype SARDs.
Язык: Английский